The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: SPOG 2015 FN Definition. A Multi-center Non-inferiority Trial on Safety of a High Versus Low Temperature Limit Defining Fever in Pediatric Patients With Cancer at Risk for Fever in Chemotherapy-induced Neutropenia
Official Title: SPOG 2015 FN Definition. A Swiss Pediatric Oncology Group (SPOG) Initiated Multi-center Open-label Randomized Controlled Multiple Crossover Non-inferiority Trial on Safety of a High Versus Low Temperature Limit Defining Fever in Pediatric Patients With Cancer at Risk for Fever in Chemotherapy-induced Neutropenia (FN)
Study ID: NCT02324231
Brief Summary: In a multi-center open-label cluster-randomized controlled parallel-group multiple crossover non-inferiority trial in children and adolescents up to 20 years diagnosed with cancer requiring chemotherapy, primarily the safety, and secondarily the efficacy and other endpoints, of a high (39.0°C) versus low (38.5°C) temperature limit defining fever (TLDF) for the diagnosis of fever in chemotherapy-induced neutropenia (FN) is studied. Safety is assessed by the rate of safety relevant events per chemotherapy exposure time, a composite endpoint including serious medical complications and bacteremia during FN. Patients are repeatedly randomized (cluster: study site) to the high or the low TLDF every month, resulting in possible multiple crossovers in one patient. The high TLDF is declared not to be inferior regarding safety compared to the low TLDF if non-inferiority of the rate ratio of safety relevant events is proven, with a single-sided non-inferiority margin of 1.33, applying mixed Poisson regression.
Detailed Description:
Minimum Age: 1 Year
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Basel: Universitätskinderklinik beider Basel, Basel, , Switzerland
Bern: Universitätsklinik für Kinderheilkunde, Inselspital, Bern, , Switzerland
Geneva: Département de Pédiatrie, Hôpital Cantonal de Genève, Geneva, , Switzerland
Lausanne: Hémato-Oncologie Pédiatrique, CHUV, Lausanne, , Switzerland
Luzern: Pädiatrische Hämatologie/Onkologie, Kinderspital, Lucerne, , Switzerland
Zürich: Pädiatrische Onkologie Kinderspital, Zurich, , Switzerland
Name: Roland A Ammann, MD
Affiliation: Universitätsklinik für Kinderheilkunde, Inselspital, Bern
Role: STUDY_CHAIR